Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Baxter International Inc. stock logo
BAX
Baxter International
$30.60
-2.4%
$30.21
$26.25
$40.49
$15.70B0.614.41 million shs2.89 million shs
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$75.12
-1.0%
$74.54
$58.93
$95.25
$44.06B1.125.23 million shs2.64 million shs
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$522.70
-0.8%
$473.11
$356.14
$530.73
$42.04B1.55649,556 shs411,464 shs
ResMed Inc. stock logo
RMD
ResMed
$249.16
-1.2%
$236.81
$179.42
$263.05
$36.53B0.781.01 million shs427,411 shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Baxter International Inc. stock logo
BAX
Baxter International
-2.36%+1.09%+1.16%-11.67%-8.14%
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
-0.98%-3.15%-2.49%+8.29%-14.40%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
-0.80%-0.42%+2.61%+25.86%+1.64%
ResMed Inc. stock logo
RMD
ResMed
-1.07%-1.23%+1.03%+10.99%+18.16%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Baxter International Inc. stock logo
BAX
Baxter International
4.4025 of 5 stars
2.23.01.74.02.71.72.5
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
4.5609 of 5 stars
2.25.00.04.03.02.52.5
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
3.7921 of 5 stars
1.45.00.03.73.02.51.3
ResMed Inc. stock logo
RMD
ResMed
4.044 of 5 stars
2.31.03.34.62.31.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Baxter International Inc. stock logo
BAX
Baxter International
2.44
Hold$37.2521.73% Upside
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
2.40
Hold$80.206.76% Upside
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
2.78
Moderate Buy$546.004.46% Upside
ResMed Inc. stock logo
RMD
ResMed
2.60
Moderate Buy$259.334.08% Upside

Current Analyst Ratings Breakdown

Latest BAX, EW, IDXX, and RMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/11/2025
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$515.00 ➝ $580.00
6/2/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Dbs Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/22/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$84.00 ➝ $95.00
5/20/2025
ResMed Inc. stock logo
RMD
ResMed
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight ➝ Overweight$286.00
5/19/2025
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$460.00 ➝ $510.00
5/13/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$80.00 ➝ $83.00
5/5/2025
Baxter International Inc. stock logo
BAX
Baxter International
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$30.00 ➝ $28.00
5/5/2025
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$548.00 ➝ $558.00
5/2/2025
Baxter International Inc. stock logo
BAX
Baxter International
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$36.00 ➝ $33.00
4/25/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$71.00 ➝ $75.00
4/24/2025
ResMed Inc. stock logo
RMD
ResMed
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$274.00
(Data available from 6/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Baxter International Inc. stock logo
BAX
Baxter International
$10.77B1.46$4.74 per share6.45$16.69 per share1.83
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$5.52B7.98$2.78 per share27.04$11.08 per share6.78
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$3.93B10.69$13.09 per share39.92$19.48 per share26.83
ResMed Inc. stock logo
RMD
ResMed
$5.02B7.28$9.88 per share25.23$35.77 per share6.97
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Baxter International Inc. stock logo
BAX
Baxter International
-$649M-$1.10N/A11.210.93-5.05%16.67%4.93%8/5/2025 (Estimated)
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$4.17B$7.0010.7827.324.8272.93%19.40%14.37%7/23/2025 (Estimated)
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$887.87M$10.8248.9938.493.4122.78%55.82%26.48%8/5/2025 (Estimated)
ResMed Inc. stock logo
RMD
ResMed
$1.02B$8.9129.4224.051.5325.34%26.17%18.60%7/30/2025 (Estimated)

Latest BAX, EW, IDXX, and RMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2025Q1 2025
Baxter International Inc. stock logo
BAX
Baxter International
$0.48$0.62+$0.14$0.25$2.59 billion$2.63 billion
5/1/2025Q1 2025
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$2.93$2.96+$0.03$2.96$998.25 million$998.43 million
4/23/2025Q1 2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$0.60$0.64+$0.04$0.61$1.40 billion$1.41 billion
4/23/2025Q3 2025
ResMed Inc. stock logo
RMD
ResMed
$2.36$2.37+$0.01$2.48$1.28 billion$1.29 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Baxter International Inc. stock logo
BAX
Baxter International
$0.682.22%N/AN/A N/A
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
N/AN/AN/AN/AN/A
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
N/AN/AN/AN/AN/A
ResMed Inc. stock logo
RMD
ResMed
$2.120.85%N/A23.79%13 Years

Latest BAX, EW, IDXX, and RMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/6/2025
Baxter International Inc. stock logo
BAX
Baxter International
quarterly$0.172.27%5/30/20255/30/20257/1/2025
4/24/2025
ResMed Inc. stock logo
RMD
ResMed
quarterly$0.530.9%5/8/20255/8/20256/12/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Baxter International Inc. stock logo
BAX
Baxter International
1.31
1.43
1.09
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
0.06
3.46
2.89
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.28
1.31
0.95
ResMed Inc. stock logo
RMD
ResMed
0.13
3.33
2.29

Institutional Ownership

CompanyInstitutional Ownership
Baxter International Inc. stock logo
BAX
Baxter International
90.19%
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
79.46%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
87.84%
ResMed Inc. stock logo
RMD
ResMed
54.98%

Insider Ownership

CompanyInsider Ownership
Baxter International Inc. stock logo
BAX
Baxter International
0.20%
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
1.29%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.98%
ResMed Inc. stock logo
RMD
ResMed
0.71%
CompanyEmployeesShares OutstandingFree FloatOptionable
Baxter International Inc. stock logo
BAX
Baxter International
60,000513.18 million509.47 millionOptionable
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
17,300586.60 million582.19 millionOptionable
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
10,80080.42 million80.16 millionOptionable
ResMed Inc. stock logo
RMD
ResMed
8,160146.63 million145.82 millionOptionable

Recent News About These Companies

Analysts Set ResMed Inc. (NYSE:RMD) PT at $259.33
ResMed: A Sleeping Giant Hiding In Plain Sight
3 Cash-Heavy Stocks with Competitive Advantages

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Baxter International stock logo

Baxter International NYSE:BAX

$30.60 -0.76 (-2.42%)
Closing price 06/13/2025 03:59 PM Eastern
Extended Trading
$31.12 +0.52 (+1.72%)
As of 06/13/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Edwards Lifesciences stock logo

Edwards Lifesciences NYSE:EW

$75.12 -0.77 (-1.02%)
Closing price 06/13/2025 03:59 PM Eastern
Extended Trading
$75.41 +0.29 (+0.39%)
As of 06/13/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

IDEXX Laboratories stock logo

IDEXX Laboratories NASDAQ:IDXX

$522.70 -4.22 (-0.80%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$523.22 +0.52 (+0.10%)
As of 06/13/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

ResMed stock logo

ResMed NYSE:RMD

$249.16 -3.05 (-1.21%)
Closing price 06/13/2025 03:59 PM Eastern
Extended Trading
$249.35 +0.19 (+0.08%)
As of 06/13/2025 07:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.